Harrow Health, Inc.HROWNASDAQ
Loading
EBITDA Over TimeExpanding
Percentile Rank100
3Y CAGR+100.2%
5Y CAGR+70.8%
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

3Y CAGR
+100.2%/yr
Annual compound
5Y CAGR
+70.8%/yr
Recent acceleration
Percentile
P100
Near historical high
vs 5Y Ago
14.6x
Strong expansion
Streak
3 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$38.09M+72.1%
2024$22.13M+85.2%
2023$11.95M+151.5%
2022$4.75M-6.9%
2021$5.10M+95.0%
2020$2.62M+37.2%
2019$1.91M+156.6%
2018$-3.37M+67.6%
2017$-10.40M+26.6%
2016$-14.17M-